-+ 0.00%
-+ 0.00%
-+ 0.00%

CARDIOL THERAPEUTICS - INITIATED PIVOTAL PHASE III MAVERIC TRIAL OF CARDIOLRX IN RECURRENT PERICARDITIS, SURPASSED 50% PATIENT ENROLLMENT

Reuters·04/01/2026 11:32:28

Please log in to view news